Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NASDAQ: ELOX) | Delayed: 13.74 -1.44 (9.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.18 | 52 Week High | $ | |||
| Open | $15.02 | 52 Week Low | $ | |||
| Day High | $15.29 | P/E | N/A | |||
| Day Low | $13.21 | EPS | $ | |||
| Volume | 31,308 | |||||
